Most of TMREs, including TAT, HPD, DDC, GOT1, COMT, GSTZ1, LCMT1, and FAH were significantly upregulated (P < 0.05), while GOT2 and ADH5 were significantly deregulated in prostate cancer tissues (Figure 1(a)). This evidence concerns the gene GOT2 and prostate carcinoma.